These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 37104212
1. Botulinum Toxin Type A for the Treatment of Auriculotemporal Neuralgia-A Case Series. Tereshko Y, Belgrado E, Lettieri C, Gigli GL, Valente M. Toxins (Basel); 2023 Apr 06; 15(4):. PubMed ID: 37104212 [Abstract] [Full Text] [Related]
7. The Therapeutic Effect of Botulinum Toxin Type A on Trigeminal Neuralgia: Are There Any Differences between Type 1 versus Type 2 Trigeminal Neuralgia? Tereshko Y, Valente M, Belgrado E, Dalla Torre C, Dal Bello S, Merlino G, Gigli GL, Lettieri C. Toxins (Basel); 2023 Nov 14; 15(11):. PubMed ID: 37999517 [Abstract] [Full Text] [Related]
9. Botulinum toxin and intractable trigeminal neuralgia. Türk U, Ilhan S, Alp R, Sur H. Clin Neuropharmacol; 2005 Nov 14; 28(4):161-2. PubMed ID: 16062093 [Abstract] [Full Text] [Related]
10. Pulsed Radiofrequency for Auriculotemporal Neuralgia: A Case Report. Tereshko Y, Belgrado E, Lettieri C, Dal Bello S, Merlino G, Gigli GL, Valente M. Neurol Int; 2024 Mar 12; 16(2):349-355. PubMed ID: 38525705 [Abstract] [Full Text] [Related]
12. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A. Guardiani E, Sadoughi B, Blitzer A, Sirois D. Laryngoscope; 2014 Feb 12; 124(2):413-7. PubMed ID: 23818108 [Abstract] [Full Text] [Related]
14. Botulinum toxin A and neuropathic pain: An update. Spagna A, Attal N. Toxicon; 2023 Aug 15; 232():107208. PubMed ID: 37385479 [Abstract] [Full Text] [Related]
15. OnabotulinumtoxinA Reduces Temporal Pain Processing at Spinal Level in Patients with Lower Limb Spasticity. De Icco R, Perrotta A, Berra E, Allena M, Alfonsi E, Tamburin S, Serrao M, Sandrini G, Tassorelli C. Toxins (Basel); 2019 Jun 20; 11(6):. PubMed ID: 31226803 [Abstract] [Full Text] [Related]
16. Botulinum toxin type A improves pain in numb chin syndrome. Tereshko Y, Hector Ercole B, Christian L, Belgrado E, Dal Bello S, Giovanni M, Luigi Gigli G, Valente M. Toxicon; 2024 Feb 01; 238():107565. PubMed ID: 38159684 [Abstract] [Full Text] [Related]
19. Effect of subcutaneous injection of botulinum toxin A on spinal cord injury-associated neuropathic pain. Han ZA, Song DH, Chung ME. Spinal Cord; 2014 Jun 01; 52 Suppl 1():S5-6. PubMed ID: 24902645 [Abstract] [Full Text] [Related]
20. The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials. Wei J, Zhu X, Yang G, Shen J, Xie P, Zuo X, Xia L, Han Q, Zhao Y. Brain Behav; 2019 Oct 01; 9(10):e01409. PubMed ID: 31541518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]